Geode Capital Management, LLC Catabasis Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
N/A
-188,799 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
N/A
-117,267 Reduced 38.31%
188,799 $398,000
Q1 2021

May 12, 2021
BUY
N/A
59,217 Added 23.99%
306,066 $884,000
Q4 2020

Feb 12, 2021
BUY
N/A
16,270 Added 7.06%
246,849 $528,000
Q3 2020

Nov 13, 2020
BUY
N/A
978 Added 0.43%
230,579 $1.43 Million
Q2 2020

Aug 13, 2020
BUY
N/A
123,813 Added 117.04%
229,601 $1.48 Million
Q1 2020

May 14, 2020
BUY
N/A
25,245 Added 31.34%
105,788 $439,000
Q4 2019

Feb 13, 2020
BUY
N/A
718 Added 0.9%
80,543 $476,000
Q2 2019

Aug 14, 2019
BUY
N/A
1,462 Added 1.87%
79,825 $644,000
Q1 2019

May 14, 2019
BUY
N/A
49,317 Added 169.79%
78,363 $620,000
Q4 2018

Feb 13, 2019
BUY
N/A
29,046 New
29,046 $126,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email